Endocrine oncology

Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

These data expand consideration of active surveillance of PTC in select patients with intrathyroidal suspected malignancy greater than 1 cm in diameter. Rescue surgery, if required at a later time point, appears effective.

Study context

Population
Patients with known or suspected intrathyroidal papillary thyroid cancer (PTC) up to 4 cm (Bethesda 5 or 6 cytology or "suspicious" Afirma molecular test), 2001–2021followed ≥1 year
Participants
69 patients
Outcome
Rate of adverse oncologic outcomes (mortality and recurrence) and cumulative incidence of size/volume growth
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Adverse oncologic outcomes and nodule growth · average 55 months

New lymph node or distant metastasis

0 patients

Concern for progression to dedifferentiated cancer on repeat core biopsy 17 years after start

1 patient

Increase in maximum diameter >3 mm

21%

Volume increase ≥50%

25%

Observational data: associations, not effects.

Further findings

Delayed (rescue) surgery

Underwent delayed (rescue) surgery
13 patients
Disease recurrence after rescue surgery
0

Predictors of nodule growth

Age and initial nodule size were not predictors of nodule growth

Nodules ≥2 cm

Patients with nodules 2 cm or larger
26 (38%)

Original publication

Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules. J Clin Endocrinol Metab. Published 13 February 2024. doi:10.1210/clinem/dgae082

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.